President and COO Preston Klassen resigns; CMO Chris Cabell assumes duties

Zura Bio Ltd

Preston Klassen resigns as President and COO effective April 11, 2023.
CMO Chris Cabell will take over Klassen's duties.
Separation agreement accelerates 59,594 stock options; shares subject to 18-month lockup.
Klassen receives no additional severance beyond option vesting and net cashless exercise.
No cause for departure stated; agreement includes standard release and non-disparagement.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Chris Cabell

Chief Medical Officer and Executive Vice President

ZURA · Zura Bio Ltd

Filed: April 7, 2023, 7:59 PM ET

Chris Cabell, the Company’s Chief Medical Officer and Executive Vice President, will be taking on Dr. Klassen’s duties going forward.

Departed

Preston Klassen

President and Chief Operating Officer

ZURA · Zura Bio Ltd

Effective: 2023-04-11
Successor: Chris Cabell
Filed: April 7, 2023, 7:59 PM ET

On April 6, 2023, Preston Klassen notified Zura Bio Limited (the “Company”) that he intended to resign as the Company’s President and Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Chris Cabell changed role as Chief Medical Officer and Executive Vice President at Zura Bio Ltd.

Action: taking on duties of President and Chief Operating Officer
Role: Chief Medical Officer and Executive Vice President

Exact text from the filing

Chris Cabell, the Company’s Chief Medical Officer and Executive Vice President, will be taking on Dr. Klassen’s duties going forward.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Preston Klassen resigned as President and Chief Operating Officer at Zura Bio Ltd.

Action: resigned
Role: President and Chief Operating Officer

Exact text from the filing

On April 6, 2023, Preston Klassen notified Zura Bio Limited (the “Company”) that he intended to resign as the Company’s President and Chief Operating Officer.

View on SEC.gov

Zura Bio Ltd filing history →

Source: SEC EDGAR

accession 0001104659-23-043201

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.